Special Issue "National Symposium of Italian Pharmaceutical Technology Association (ADRITELF)"

A special issue of Journal of Functional Biomaterials (ISSN 2079-4983).

Deadline for manuscript submissions: closed (30 April 2013)

Special Issue Editors

Guest Editor
Prof. Dr. Nevio Picci

Pharmaceutical Sciences Department, University of Calabria, Edificio Polifunzionale, Arcavacata di Rende (CS) 87036, Italy
Website | E-Mail
Interests: micro and nano polymeric particles in biomedical fields; vescicles for drug delivery systems; Nanocomposites for biomedical use
Guest Editor
Prof. Dr. Giovanna Pitarresi

Dipartimento di Scienze e Tecnologie Molecolari e Biomolecolari, Sezione di Chimica e Tecnologie Farmaceutiche, Università degli Studi di Palermo, Via Archirafi 32, 90123, Palermo, Italy
Website | E-Mail
Interests: synthesis, physicochemical and biological characterization of biocompatible polymers; nanosystems and hydrogels for drug modified release; scaffolds for tissue engineering

Special Issue Information

Dear Colleagues,

From many years, Italian research in drug delivery holds an important position both in national and international field. The reason of this success is related to the originality and continuous innovation of the systems that are proposed for modified and/or controlled release of bioactive molecules, as conventional drugs, peptides, genic material. In many cases, to prepare these systems, biocompatible polymers (natural, synthetic and their combination) are used. The polymeric material, appropriately chosen (or synthesized) confers peculiar properties to the system, e.g. biocompatibility, biodegradability (if necessary), targeting towards pathological site, prolonged blood circulation time, etc. Similarly, the use of lipids, phospholipids, cyclic oligosaccharides, gives the opportunity to prepare optimal systems for the drug delivery. By using the appropriate biomaterials and preparation/synthetic procedures, it is possible to obtain systems with different shape and size ranging from nanometer to macroscopic scale.

The aim of this special issue is to present the emerging approaches of Italian research groups  in the field of drug delivery with a particular emphasis on the employment of new technologies for this purpose.

Prof. Dr. Nevio Picci
Prof. Dr. Giovanna Pitarresi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Functional Biomaterials is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 550 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • polymeric materials
  • lipids
  • phospholipids
  • cyclodextrins
  • liposomes
  • niosomes
  • micelles
  • macromolecular prodrugs
  • nanoparticles
  • dendrimers
  • microparticles
  • hydrogels

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to Top